News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Encorafenib, cetuximab, and chemotherapy in BRAF-mutant colorectal cancer
Feb 2, 2025, 04:22

Encorafenib, cetuximab, and chemotherapy in BRAF-mutant colorectal cancer

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared a paper by Scott Kopetz et al. on X:

“Encorafenib, cetuximab, and chemotherapy in BRAF-mutant colorectal cancer:

  • BREAKWATER Phase 3 trial
  • ORR 60% vs. 40.0%
  • DoR 13.9 vs. 11.1 months
  • OS NE vs. 14.6 months

New SOC for BRAF mutant CRC”

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

Authors: Scott Kopetz, Takayuki Yoshino, Eric Van Cutsem, Cathy Eng, Tae Won Kim, Harpreet Singh Wasan, Jayesh Desai, Fortunato Ciardiello, Rona Yaeger, Timothy S. Maughan, Elena Beyzarov, Xiaoxi Zhang, Graham Ferrier, Xiaosong Zhang & Josep Tabernero

Encorafenib, cetuximab, and chemotherapy in BRAF-mutant colorectal cancer

Arndt Vogel BRAF mutant CRC BRAF mutation BREAKWATER trial cancer Cancer research cancer treatment cetuximab chemotherapy clinical trials colorectal cancer CRC outcomes encorafenib ESMO Nature Medicine OncoDaily Oncology Phase 3 Trial Precision Oncology SoC survival data targeted therapy
Special Coverage
Blog
May 20, 2025, 17:22
The Lancet Group's Editorial Team Will Be on the Ground at ASCO 2025
Blog
May 20, 2025, 17:11
Pam Traxel: One in Ten Cancer Survivors Rely on Medicaid - Cuts Have Consequences
Blog
May 20, 2025, 16:58
Elvina Majiwa and Murallitharan Munisamy Have Won The World No Tobacco Day Award - UICC
Blog
May 20, 2025, 16:56
PER Tumor Board: Applying Recent Advances to Transform the Treatment Paradigm in SCLC
Blog
May 20, 2025, 16:46
Shahrin Ahmed: Specific Pre-surgery Medication Improves Survival Rates in Hereditary Breast Cancer Cases
Blog
May 20, 2025, 16:43
Ahmed Magdy Rabea: Pleased to Give a Multiple Myeloma Awareness Session to the Pfizer Egypt Team
Blog
May 20, 2025, 16:37
Sachin Jain: The Greatest Impact of AI Will Come from Improving Care and Service
Blog
May 20, 2025, 16:27
It Is Time to Invest in Cancer Research - Stand Up To Cancer
Insight
May 20, 2025, 15:50
Oliver Bogler Announced the Launch of the NanCI AI Webapp for Scientific Literature and Networking
Blog
May 20, 2025, 15:37
Fumiko Ladd Chino: Even with Superlative Healthcare You Can Still End Up with Stage 4 Cancer
Blog
May 20, 2025, 15:20
Save the date for the 7th CCI4EU Online Course - "Early Cancer Detection, Screening, and Prevention"
Insight
May 20, 2025, 15:05
New JCO Oncology Practice Piece on Debunking Myths of Hope in Cancer Care